ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 144,43
-0,12%
Dow Jones
43 428,02
-1,69%
DAX
22 501,41
1,07%
Brent Oil
74,20
0,13%
Bitcoin
95 846,55
-0,44%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Liquidia Corporation (LQDA)

  7. Liquidia Corporation (LQDA) Actualités

LQDA

Liquidia (LQDA)

Liquidia Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:LQDA
DateHeureSourceTitreSymboleSociété
12/02/202523h34Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:LQDALiquidia Corporation
23/01/202523h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
08/01/202514h00GlobeNewswire Inc.Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:LQDALiquidia Corporation
13/11/202413h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LQDALiquidia Corporation
13/11/202412h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
13/11/202412h30GlobeNewswire Inc.Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:LQDALiquidia Corporation
12/11/202414h00GlobeNewswire Inc.Liquidia to Present at the Stifel 2024 Healthcare ConferenceNASDAQ:LQDALiquidia Corporation
06/11/202414h00GlobeNewswire Inc.Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024NASDAQ:LQDALiquidia Corporation
04/11/202414h00GlobeNewswire Inc.Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024NASDAQ:LQDALiquidia Corporation
18/10/202421h31Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:LQDALiquidia Corporation
07/10/202416h00GlobeNewswire Inc.United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ PatentNASDAQ:LQDALiquidia Corporation
02/10/202412h00GlobeNewswire Inc.Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)NASDAQ:LQDALiquidia Corporation
30/09/202414h00GlobeNewswire Inc.Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual MeetingNASDAQ:LQDALiquidia Corporation
16/09/202415h41GlobeNewswire Inc.Court Finds United Therapeutics’ Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 MillionNASDAQ:LQDALiquidia Corporation
11/09/202422h41Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:LQDALiquidia Corporation
11/09/202414h29Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:LQDALiquidia Corporation
11/09/202414h26GlobeNewswire Inc.Liquidia Corporation Announces Raise of $67.5 Million from New Common Stock Financings and $32.5 Million Advance from HealthCare Royalty Under Current Financing AgreementNASDAQ:LQDALiquidia Corporation
28/08/202414h00GlobeNewswire Inc.Liquidia to Present at Upcoming Investor ConferencesNASDAQ:LQDALiquidia Corporation
22/08/202412h00GlobeNewswire Inc.Liquidia Files Litigation to Challenge Regulatory Exclusivity Blocking Access to YUTREPIA™ (treprostinil) inhalation powder for Patients Suffering with PAH and PH-ILDNASDAQ:LQDALiquidia Corporation
19/08/202412h00GlobeNewswire Inc.U.S. FDA Grants Tentative Approval of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)NASDAQ:LQDALiquidia Corporation
16/08/202412h30GlobeNewswire Inc.Liquidia Announces Poster Presentations at the PHA 2024 International PH Conference and Scientific SessionsNASDAQ:LQDALiquidia Corporation
07/08/202412h30GlobeNewswire Inc.Liquidia Corporation Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:LQDALiquidia Corporation
31/07/202414h00GlobeNewswire Inc.Liquidia Corporation to Report Second Quarter 2024 Financial Results on August 7, 2024NASDAQ:LQDALiquidia Corporation
08/07/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LQDALiquidia Corporation
18/06/202414h42GlobeNewswire Inc.Liquidia Announces Poster Presentations at the 7th World Symposia on Pulmonary Hypertension (WSPH)NASDAQ:LQDALiquidia Corporation
03/06/202413h00GlobeNewswire Inc.District Court Issues Favorable Ruling and Denies United Therapeutics’ Request to Block YUTREPIA™ LaunchNASDAQ:LQDALiquidia Corporation
29/05/202414h00GlobeNewswire Inc.Liquidia Corporation to Present at the 2024 Jefferies Global Healthcare ConferenceNASDAQ:LQDALiquidia Corporation
13/05/202423h43GlobeNewswire Inc.Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:LQDALiquidia Corporation
10/05/202414h00GlobeNewswire Inc.Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILDNASDAQ:LQDALiquidia Corporation
07/05/202414h30GlobeNewswire Inc.Liquidia Corporation to Present at BofA Securities Health Care Conference 2024NASDAQ:LQDALiquidia Corporation
 Showing the most relevant articles for your search:NASDAQ:LQDA

Dernières Valeurs Consultées

NASDAQ
AAPL
Apple
EU
ML
Michelin
NASDAQ
NVDA
NVIDIA
EU
GLE
Societe Generale
EU
PX4
SBF 120
EU
CAP
Capgemini
EU
AF
Air FranceKLM
NASDAQ
MSFT
Microsoft
EU
MC
Lvmh Moet Hennessy Louis...
EU
AI
Air Liquide
NYSE
MCD
McDonalds
FTSE
UKX
FTSE 100
NYSE
MRK
Merck
EU
RI
Pernod Ricard
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces